Neurodegenerative Disease Peptides
3 articles in this topic.
Neurodegenerative Disease Peptides
Peptide Therapeutics for Parkinson's: The Evidence
Peptide approaches to Parkinson's disease target alpha-synuclein aggregation and neuroinflammation. Here is what clinical and preclinical research shows.
14 min read|Mar 25, 2026
Neurodegenerative Disease Peptides
NAP Peptide (Davunetide): The Neuroprotective Peptide Story
Davunetide (NAP) is an 8-amino-acid peptide that stabilizes microtubules, reduces tau pathology, and reached Phase 2/3 trials for PSP and cognitive decline.
16 min read|Mar 23, 2026
Neurodegenerative Disease Peptides
Huntington's Peptide Research: Targeting Toxic Proteins
Peptide-based approaches to Huntington's disease target polyglutamine aggregation, deliver drugs across the blood-brain barrier, and offer neuroprotection.
13 min read|Mar 22, 2026